Martin Smith
Chief Tech/Sci/R&D Officer at IDEXX LABORATORIES, INC.
Net worth: 256 467 $ as of 2024-03-30
Profile
Martin Alexander Smith is currently the Chief Technology Officer & Executive VP at IDEXX Laboratories, Inc. Prior to this, he held the position of Chief Technology Officer at Pall Corp.
from 2014 to 2020.
He also served as the Chief Technology Officer & Vice President at Cytiva from 2020 to 2021.
Dr. Smith's education includes a graduate degree from The University of Reading, an undergraduate degree from the University of Essex, and a doctorate from University College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IDEXX LABORATORIES, INC.
0.00% | 2024-02-13 | 475 ( 0.00% ) | 256 467 $ | 2024-03-30 |
Martin Smith active positions
| Companies | Position | Start |
|---|---|---|
| IDEXX LABORATORIES, INC. | Chief Tech/Sci/R&D Officer | 2021-07-31 |
Former positions of Martin Smith
| Companies | Position | End |
|---|---|---|
Global Life Sciences Solutions USA LLC
 Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a private company that manufactures therapeutics. The company is based in Marlborough, MA. | Chief Tech/Sci/R&D Officer | 2021-06-30 |
| PALL CORPORATION | Chief Tech/Sci/R&D Officer | 2020-07-31 |
Training of Martin Smith
| The University of Reading | Graduate Degree |
| University of Essex | Undergraduate Degree |
| University College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IDEXX LABORATORIES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a private company that manufactures therapeutics. The company is based in Marlborough, MA. | Health Technology |
- Stock Market
- Insiders
- Martin Smith
